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Pdx1 and Oc1 are co-expressed in multipotent
pancreatic progenitors and regulate the pro-endo-
crine gene Neurog3. Their expression diverges in
later organogenesis, with Oc1 absent from hor-
mone+ cells and Pdx1 maintained in mature b cells.
In a classical genetic test for cooperative functional
interactions, we derived mice with combined Pdx1
and Oc1 heterozygosity. Endocrine development in
double-heterozygous pancreata was normal at em-
bryonic day (E)13.5, but defects in specification and
differentiation were apparent at E15.5, the height of
the second wave of differentiation. Pancreata from
double heterozygotes showed alterations in the
expression of genes crucial for b-cell development
and function, decreased numbers and altered alloca-
tion of Neurog3-expressing endocrine progenitors,
and defective endocrine differentiation. Defects in
islet gene expression and b-cell function persisted
in double heterozygous neonates. These results sug-
gest thatOc1 andPdx1 cooperate prior to their diver-
gence, in pancreatic progenitors, to allow for proper
differentiation and functional maturation of b cells.
INTRODUCTION
Knowledge gained from developmental biology has been in-
strumental in deriving glucose-responsive, insulin-secreting
pancreatic b cells from embryonic stem cells (ESCs) or induced
pluripotent stem cells (iPSCs) to generate a cell-based therapy
for the treatment of diabetes (Bruin et al., 2015; Pagliuca et al.,This is an open access article under the CC BY-N2014; Russ et al., 2015). Of particular interest are signaling mol-
ecules and transcriptional regulators that direct the b-cell fate or
generate fully functional b cells. Many elegant single gene inac-
tivation studies have revealed critical roles for specific transcrip-
tion factors in different stages of pancreas development and
endocrine differentiation. However, few studies have analyzed
the functional consequences of combinatorial genetic manipula-
tions of structurally unrelated pancreas transcription factors dur-
ing development (Burlison et al., 2008; Courtney et al., 2013;
Shih et al., 2015), Here, we report on the genetic and functional
cooperativity of the Pdx1 and Oc1 transcription factors and the
requirement for a combined threshold of activity in setting up a
genetic program for endocrine differentiation and b-cell function.
Pancreatic and duodenal homeobox 1 (Pdx1) is required for
pancreas development, endocrine differentiation, and mature
b-cell function in mouse and human (Gao et al., 2014; Jonsson
et al., 1994; Lammert et al., 2001; Offield et al., 1996; Stoffers
et al., 1997b, 1997c, 1998). Pdx1 is initially expressed in the
mouse posterior foregut endoderm at embryonic day (E)8.5,
expanding into the antral stomach, rostral duodenum, and com-
mon bile duct by E11.5 and maintained at high levels in mature b
cells (Guz et al., 1995; Jonsson et al., 1994; Offield et al., 1996;
Wu et al., 1997). In addition, the burst of b-cell proliferation that
occurs just prior to birth requires Pdx1 (Gannon et al., 2008).
Beginning at late gestation and continuing into the early post-
natal period, b cells undergo gene expression changes associ-
ated with functional maturation, including the acquisition of
tightly controlled glucose-stimulated insulin secretion (Artner
et al., 2010; Nishimura et al., 2006; Stolovich-Rain et al., 2015).
In adult mice, Pdx1 regulates b-cell function and survival (Bris-
sova et al., 2002; Dutta et al., 1998; Gauthier et al., 2009; Kulkarni
et al., 2004; Sachdeva et al., 2009; Waeber et al., 1996). The
crucial role for Pdx1 in endocrine-lineage development and
postnatal b-cell function is underscored by the identification ofCell Reports 15, 2637–2650, June 21, 2016 Array 2637
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diabetes-causing PDX1 mutations in humans (Hani et al., 1999;
Macfarlane et al., 2000; Stoffers et al., 1997a, 1998).
Onecut 1 (Oc1; also known as hepatic nuclear factor 6; Hnf6)
is expressed more broadly in the developing endoderm and
plays roles in the developing liver and pancreas (Jacquemin
et al., 2000, 2003; Samadani et al., 1996; Zhang et al., 2009).
Expression of the endocrine-progenitor transcription factor,
neurogenin 3 (Neurog3), is nearly undetectable in Oc1/ em-
bryos, which are diabetic at birth, with a near complete loss of
all pancreatic endocrine cell lineages (Jacquemin et al., 2000).
Oc1 binds to an upstream enhancer from the Neurog3 gene
(Jacquemin et al., 2000), suggesting that Neurog3 is a direct
transcriptional target of Oc1. Unlike Pdx1, Oc1 is not expressed
in differentiated, hormone-positive endocrine cells, but its
expression persists in ducts and acinar cells into adulthood
(Pekala et al., 2014; Pre´vot et al., 2012; Rausa et al., 1997; Zhang
et al., 2009). Overexpression of Oc1 in the developing pancreas
results in an increase in Neurog3-positive cells (Wilding Crawford
et al., 2008). However, its downregulation in the endocrine line-
age is essential: maintained Oc1 expression prevents b-cell
maturation, most likely by directly inhibiting expression of the
b-cell transcription factor,MafA (Yamamoto et al., 2013), and re-
sults in diabetes (Gannon et al., 2000; Tweedie et al., 2006).
Pdx1 and Oc1 are coexpressed in multipotent pancreatic
progenitors (MPCs) in the early pancreatic bud and later in the
undifferentiated, bipotential duct/endocrine cell pool located
within the ‘‘trunk’’ domain of the pancreatic epithelium. Pdx1
and Oc1 each activate Neurog3 expression and our in vitro evi-
dence suggests that a physical interaction between these two
factors involving the Pdx1 C terminus promotes endocrine spec-
ification. Pdx1 occupies an evolutionarily conserved Neurog3
enhancer at E13.5 and, in reporter assays, Pdx1 transactivation
via this enhancer was significantly enhanced by Oc1. Mice
homozygous for a Pdx1 allele with a premature C-terminal trun-
cation (Pdx1DC/DC) display a global reduction in endocrine line-
ages and decreased numbers of Neurog3+ progenitors at
E13.5 (Oliver-Krasinski et al., 2009).
We hypothesized that the Pdx1-Oc1 interaction is critical at
multi- or bipotent stages to promote the specification of
pancreatic endocrine progenitors by regulating Neurog3 and
other developmentally important genes. To assess the signifi-
cance of the Pdx1-Oc1 interaction in vivo, we generated ani-
mals globally heterozygous for either or both genes. To date,
no developmental phenotype for either single heterozygous an-
imal has been reported. At E13.5, double heterozygotes
showed normal numbers of glucagon+ and Neurog3+ cells,
suggesting that the first wave of endocrine differentiation is un-
affected. By E15.5 at the height of the secondary wave of dif-
ferentiation, the numbers of Neurog3+ endocrine progenitors
and insulin+ and glucagon+ cells were reduced. Whole tran-
scriptome analysis at E15.5 revealed a dramatic and unique
impact of Pdx1-Oc1 heterozygosity on the endocrine compart-
ment. Later stages of endocrine differentiation and function,
well after the normal downregulation of Oc1 in the endocrine
lineage, were also defective in double heterozygotes. Thus,
Pdx1 and Oc1 cooperate to promote endocrine specification
and subsequent functional maturation of b-cells, most likely
by establishing a state of competency in progenitors earlier in2638 Cell Reports 15, 2637–2650, June 21, 2016development that allows for later steps in endocrine differenti-
ation to be realized.
RESULTS
Combined Pdx1 and Oc1 Heterozygosity Has a Broad
Effect on the Transcriptional Network Regulating
Endocrine Development
To determine the effect of combined global heterozygosity for
Pdx1 and Oc1 on pancreas development, we analyzed the
transcriptome of pancreata from control (WT), Pdx1lacZ/+
(which carry one null allele of Pdx1 containing a lacZ cassette;
Offield et al., 1996), Oc1+/, and Pdx1lacZ/+;Oc1+/ (hereafter:
double heterozygous, DH) animals using RNA-sequencing
(RNA-seq; see Supplemental Information). We performed our
analysis at E15.5 since all pancreatic lineages are present at
this stage and the greatest number of Neurog3+ cells can be
detected (Gradwohl et al., 2000). A total of 2,331 genes were
differentially expressed in at least one of the three experi-
mental genotypes (Figure 1A; Table S1). Expression of 102
genes was altered in Pdx1lacZ/+ pancreata (Figure 1B).
Oc1+/ pancreata showed the greatest number of gene
expression changes, with more than 2,000 genes affected. In
contrast to Pdx1 single-heterozygotes (SH), b-cell genes
such as Ins1, Ins2, and Iapp were increased in Oc1+/ SH,
consistent with a role for Oc1 in suppressing b-cell differentia-
tion (Tweedie et al., 2006).
The transcriptome of Pdx1-Oc1 double heterozygotes
showed a pattern of gene dysregulation distinct from either SH
transcriptome. Of the 257 genes affected in DH, 153 genes
were specifically altered in DH compared to WT (Figure 1B),
including key transcriptional regulators MafA, MafB, NeuroD1,
and Nkx6.1, providing strong support for functional cooperation
between these two transcription factors to regulate a distinctive
genetic program. Furthermore, the shift of gene expression pat-
terns of Oc1+/ SH versus DH or Pdx1lacZ/+ SH versus DH (Fig-
ure 1A) suggests the Pdx1-Oc1 interaction acts cooperatively
or antagonistically at the level of broad categories of genes.
To assess systematic changes in expression of genes involved
in canonical signaling pathways, disease and biological function
categories, and molecular networks of genes altered in the three
experimental genotypes, we performed comparison-enrichment
analysis using Ingenuity Pathway Analysis (IPA). The top gene
ontology categories ascribed to genes altered in Oc1+/ or in
Pdx1lacZ/+ SH pancreata were ‘‘cancer’’, ‘‘embryonic develop-
ment’’ and ‘‘cellular development’’, or ‘‘gene expression’’,
respectively (Table S2). The genes altered in DH pancreata
clustered primarily in the ‘‘endocrine system development and
function’’, ‘‘carbohydrate metabolism’’, and ‘‘endocrine system
disorders’’ categories (Figure 1C; Table S2). The ‘‘endocrine sys-
tem development and function’’ category was enriched for
genes associated with ‘‘quantity of endocrine cells’’ and ‘‘quan-
tity of beta and alpha islet cells’’ (Table 1), indicating a possible
impact on endocrine progenitors and endocrine differentiation.
Genes in these categories clustered less strongly in Pdx1lacZ/+
or Oc1+/ SH because the vast majority of genes were specif-
ically altered in the DH data set and not in SH pancreata (Figures
1C and 1D; Table 1).
Figure 1. Combined Heterozygous Reduc-
tion in Pdx1 and Oc1 Gene Dosage Has
a Broad Impact on the Transcriptional
Network of Endocrine Pancreas Progenitors
(A–D) Hierarchical clustering of 2,331 differentially
expressed genes in individual pancreata at E15.5
fromPdx1LacZ/+ (n=4),Oc1+/ (n=3), andPdx1LacZ/+;
OC1+/ mice (n = 5) compared to WT (n = 4) (A);
Venn diagram depicting the number of altered
genes in the Pdx1LacZ/+, Oc1+/, and Pdx1LacZ/+;
Oc1+/ (B); and endocrine system development and
function gene ontology category in each genotype,
according to negative log of p value from Fisher
exact test. The numbers above each column repre-
sent the number of genes enriched in each category
(C) and the heatmap of endocrine development and
function genes (D). The up- or downregulated genes
with false discovery rate less than 0.1 and fold
change higher than 0.5 versus WT are highlighted
with bold black borders. See also Tables S1 and S2.The largest effects of DH on transcription were observed in
pancreatic endocrine-hormone expression. Insulin was most
affected in the DH pancreata, being significantly reduced
compared to both WT and SH animals (Figure 1D). mRNA levels
of other islet hormones (Gcg, Iapp, and Sst) were also decreased
in the DH animals by 30%–50% compared to WT or SH pan-
creata, suggesting an overall synergistic action of Pdx1 and
Oc1 on the entire endocrine compartment. Within the gene set
significantly altered in DH pancreata, we also observed an
impressive array of transcription factors crucial for development
of the endocrine pancreas. The decreased expression of MafA,
MafB, Pax4, Pax6, Mnx1, Nkx2.2, and Nkx6.1 suggests that
simultaneous reduction in expression of both Pdx1 and Oc1
acts at multiple levels of endocrine differentiation and not justCellat the level of activation of Neurog3.
Expression of Neurog3 and Pax4 was
decreased inOc1 SH and DH, while neuro-
peptide Y (NPY) was decreased similarly in
the Pdx1 SH and DH compared with WT,
indicating that some genes show sensi-
tivity to reductions in either Pdx1 or Oc1
gene dosage alone.
In DH pancreata, we also observed large
decreases in expression of genes encod-
ing proteins involved in multiple aspects
of glucose-stimulated insulin secretion,
glucose metabolism (Gck and G6pc2),
KATP channel components (Abcc8 and
Kcnj11), vesicle trafficking (Scg5 and
Sytl4), G protein coupled receptors (Glp1r
and Ffar1), and transmembrane proteins
(Klb) (Figure 1D). These findings are likely
related to the decreased number of differ-
entiated endocrine cells in DH at this devel-
opmental age (see below). Although the
majority of changes were associated with
downregulation of gene expression, somegenes were upregulated in all three mutant genotypes, including
vitronectin (Vtn), which is increased in delaminating endocrine-
committed cells (Cirulli et al., 2000) and inhibits insulin pro-
duction and secretion (Kaido et al., 2006), and regenerating
islet-derived 1 (Reg1), which is associated with islet regeneration
(Kobayashi et al., 2000; Terazono et al., 1988).
Embryonic Endocrine Progenitor Specification and
Endocrine Cell Maturation during the Secondary
Transition Are Impaired by Double Pdx1-Oc1
Heterozygosity
The E15.5 RNA-seq data suggested that endocrine lineage
commitment and differentiation were impaired in DH pancreata.
Specifically, expression of Neurog3, the critical endocrineReports 15, 2637–2650, June 21, 2016 2639
Table 1. Clustering of Genes in Each Endocrine System Development and Function Gene Ontology Category in Each Experimental
Genotype
Endocrine System Development and Function Annotationa p Value Molecules
Pdx1LacZ/+
Migration of beta islet cells 4.38 3 103 Vtn
Transmembrane potential of beta islet cells 4.38 3 103 Kcnj11
Development of enteroendocrine cells 8.74 3 103 Atoh1
Replication of beta islet cells 1.31 3 102 Reg1a
Formation of parathyroid gland 1.74 3 102 Aldh1a7
Glucuronidation of beta-estradiol 1.74 3 102 Nr1i2
Differentiation of beta islet cells 2.17 3 102 Slc2a2
Oc1+/
Glucose tolerance 2.34 3 104 Abcb4, Atf4, C19orf10, Cbl, cckbr, Cyp2J2, Ffar3,
Fxyd2, Grb10, Hnf4a, Htr2c, htr3a, Hyou1, Iapp, ins,
Irs2, Klf15, Mir-802, Nrob2, Nr1h4, Pcbd1, Rbp1, Serp1,
Srebf1, and Wnt10b
Pdx1LacZ/+; Oc1+/
Quantity of endocrine cells 9.28 3 1011 Arx, Gast, Ins, Ins1, Kcnj11, Mafb, Mnx1, Neurog3,
Nkx6-1, Pax4, Pax6, and Pcsk2
Quantity of beta islet cells 2.40 3 1010 Arx, Ins, Ins1, Kcnj11, Mnx1, Nkx6-1, Pax4, and Pcsk2
Quantity of alpha islet cells 2.79 3 106 Arx, Ins, Ins1, and Pcsk2
Entry into cell-cycle progression of endocrine cell lines 2.53 3 105 Ins1, Sst, and Tf
Concentration of corticosterone 2.77 3 105 Crhr2, Gck, Glp1r, Ins, Klb, Npy, and Scg5
Glucose tolerance 1.43 3 104 Abcc8, Glp1r, Iapp, Ins, Mafa, Pdx1, Sytl4, and Tgfb3
Replication of beta islet cells 3.55 3 104 Gast and Reg1a
Differentiation of endocrine cells 1.10 3 103 Nkx6-1, Pax4, and Pdx1
Area of islets of Langerhans 1.17 3 103 Ins and Ins1
Differentiation of beta islet cells 1.17 3 103 Nkx6-1 and Pdx1
Regeneration of islet cells 1.17 3 103 Nkx6-1 and Pcsk2
Formation of islet cells 2.42 3 103 Pax6 and Pdx1
Quantity of delta islet cells 2.42 3 103 Arx and Pcsk2
Synthesis of hormone 2.88 3 103 Abcc4, Crhr2, Cyp11a1, Ins, Pax6, and Vip
Proliferation of beta islet cells 3.98 3 103 Iapp, Ins, Nkx6-1, and Pax4
Quantity of enteroendocrine cells 6.15 3 103 Arx and Pax4
Steroidogenesis of hormone 7.54 3 103 Abcc4, Crhr2, Cyp11a1, Ins, and Vip
Size of beta islet cells 8.60 3 103 Pcsk2 and Pdx1
Synthesis of corticosterone 8.60 3 103 Apoa1 and Cyp11a1
Activation of parathyroid gland 1.09 3 102 Casr
Arrest in organogenesis of pancreas 1.09 3 102 Pdx1
Binding of hypothalamus 1.09 3 102 Pyy
aSee also Figure 1 and Tables S1 and S2.specification transcription factor, and Pax6, a pan-endocrine-
lineage transcription factor downstreamof Neurog3, were down-
regulated. Pancreas development is asynchronous and multiple
developmental stages can be observed at a single time point
(Guney and Gannon, 2009). To obtain cellular resolution of
gene expression changes, we quantified the number of cells
expressing either Neurog3 or Pax6 at E15.5. DH pancreata had
approximately 50% fewer Neurog3+ endocrine progenitors
thanWT (Figures 2A and 2C). These data support our hypothesis
that combined Pdx1 and Oc1 deficiency leads to reduced endo-
crine lineage specification. Despite a reduction in Neurog32640 Cell Reports 15, 2637–2650, June 21, 2016mRNA expression in Oc1 SH (Figure 1D), the number of Neu-
rog3+ cells in Oc1 SH was not statistically significantly affected
compared to WT (Figure 2C), suggesting a decrease in Neurog3
expression per cell in Oc1 SH. Although the reduction in Pax6+
endocrine precursor cells did not achieve statistical significance
(Figures 2B and 2D), the ratio of Neurog3+ cells to Pax6+ cells at
E15.5 was similar among genotypes (Figure S1), supporting an
overall decrease in the number of specified and committed
endocrine cells. In contrast, at E13.5, Neurog3+ progenitor
numbers were not affected in SH or DH pancreata (Figure S2A).
Pax6+ and glucagon+ cells were also normal at this stage
Figure 2. Reduced Number and Altered Location of Neurog3-Expressing Endocrine Progenitors in DH Mice at E15.5
(A, B, E, and F) WT, Pdx1LacZ/+,Oc1+/, and DH pancreata were immunolabeled for Neurog3 (A, E, and F) or Pax6 (in red) (B), Pdx1 (green), and E-cadherin (blue).
(C and D) Quantification for Neurog3 (C) and Pax6 (D). The white arrows: delaminated Neurog3+ progenitors and yellow arrowheads: Neurog3+ progenitors within
developing trunk.
(A and B) 203magnification. The scale bar represents 100 mm. (E and F) 403magnification. The scale bar represents 100 mm. p value for all marked comparisons
was < 0.05 by one-way ANOVA with Tukey correction (*p = 0.0019). See also Figure S1.
Cell Reports 15, 2637–2650, June 21, 2016 2641
(Figures S2B and S2C; too few insulin+ cells were detected to
quantify). Thus, the impact of decreased Pdx1-Oc1 dosage
appears to be restricted to the second wave of endocrine differ-
entiation that gives rise to cells within the mature islets of Lang-
erhans (Guney and Gannon, 2009).
During normal pancreas development, Neurog3 expression
initiates within a subset of bipotential trunk epithelial cells
(Beucher et al., 2012) and becomes elevated in cells destined
to undergo commitment to the endocrine lineage. It is thought
that the Neurog3hi cells give rise to hormone-expressing cells af-
ter delaminating from the ductal epithelium (Villasenor et al.,
2008). Closer examination of DH pancreata at E15.5 revealed
that, in contrast to WT pancreata, fewer Neurog3+ cells could
be found within the pancreatic trunk epithelium. A greater
proportion of the Neurog3+ cells present were instead located
adjacent to the epithelium in DH compared with the other three
genotypes; these extra-truncal Neurog3+ cells seemed to ex-
press high levels of Neurog3 (Figures 2E and 2F, white arrows
compared to yellow arrows).
To characterize the impact of Pdx1-Oc1 cooperativity on the
endocrine compartment during the definitive second wave of
endocrine differentiation, we examined markers of differenti-
ated endocrine lineages at E15.5 including the hormones insu-
lin and glucagon. DH pancreata showed significant decreases
in the numbers of both insulin+ and glucagon+ cells (Figures
3A and 3B). Only DH pancreata showed a reduction in
glucagon+ cell number (Figure 3B), whereas similar decreases
in the number of insulin+ cells were observed in Pdx1 SH and
DH (Figure 3A). While previous studies have shown decreased
b-cell function and impaired glucose homeostasis in Pdx1 SH
postweaning, here, we show that defects in the b-cell lineage
exist in Pdx1 SH during embryonic development. Defective
b-cell development could contribute to the susceptibility to
mature onset diabetes of the young (MODY) and adult-onset
diabetes observed in mice and humans with heterozygous
Pdx1mutations (Dutta et al., 1998; Hani et al., 1999; Macfarlane
et al., 2000; Sachdeva et al., 2009; Stoffers et al., 1997c, 1998;
Weng et al., 2001). Taken together, these data reveal a reduc-
tion in the numbers of emerging hormone-expressing cells at
E15.5 in mice with combined reduction in Pdx1 and Oc1
gene dosage.
In light of the transcriptional impact of Pdx1 andOc1 reduction
onmarkers of a and b cell maturation (Figure 1), we assessed the
number of cells expressing the ‘‘large Maf’’ transcription factors,
MafA and MafB.MafB is activated soon after endocrine progen-
itor delamination in both glucagon+ and insulin+ cells and is
downregulated postnatally in insulin+ cells inmice.MafA expres-
sion initiates later, specifically in insulin+ cells, and is maintained
in these cells. Despite measurable decreases in MafA and MafB
transcripts (Figure 1D), we observed no differences in the total
number of MafA+ or MafB+ cells at E15.5 (Figures 3C and 3D).
Normal cell numbers in spite of reduced transcripts suggests
that MafA and MafB expression per cell is decreased. When
we compared the numbers of MafA/B+ cells to the number of
insulin/glucagon-expressing cells, we found a significant in-
crease in the number of Maf+/hormone cells in DH pancreata
(Figure S3). These Maf+ cells may derive from Neurog3+ cells
generated prior to E13.5 that fail to gainmature hormone expres-2642 Cell Reports 15, 2637–2650, June 21, 2016sion in a timely fashion. Taken together, these data further es-
tablish that the simultaneous decrease in Pdx1-Oc1 dosage
preferentially affects the endocrine progenitor program during
the second wave of endocrine differentiation.
Impaired Terminal Differentiation and Function of
Hormone+ Cells with Double Pdx1-Oc1 Heterozygosity
To determine whether the developmental defects in DH persist
after birth, we examined early postnatal stages physiologically
and morphologically. Immediately at birth, prior to feeding, there
were no significant differences in body weight or blood glucose
levels (Figure S2). However, with the start of feeding at postnatal
day 1 (P1), DH animals failed to increase in body weight
compared to the other genotypes (Figure 4A). At P1, DH pups
exhibited elevated ad lib blood glucose compared to WT and
Oc1+/ animals (Figure 4B). We therefore analyzed whether DH
neonates had reduced a- or b-cell mass, consistent with our ob-
servations of decreased insulin+ and glucagon+ cells at E15.5.
There was a strong trend toward reduced a- and b-cell mass
at P1 in Pdx1 SH and DH, but this was not statistically significant
(Figures 4G and 4H). Islet morphology (Figures 4C–4F) and a:b
cell ratio were unchanged at P1 (Figure 4I). However, there
was a dramatic and significant decrease in total pancreatic insu-
lin protein content in DH when compared with WT or either SH
(Figure 4J). These data suggest reduced insulin production per
b cell and indicate a functional b-cell defect in DH mice that per-
sists after birth in a cell population in which Pdx1 and Oc1 no
longer colocalize.
A postnatal functional defect in DH islets is also supported by
islet gene expression data at P1 (Figure 5). Taqman low density
array (TLDA) analysis revealed that P1 DH islets had undetect-
able levels of insulin and glucagon mRNA; expression of these
hormones was unaffected in islets from SH (Figure 5A). qRT-
PCR using primers spanning the insulin and glucagon transcripts
confirmed the decrease in insulin and glucagon in DH islets at P1
(Figure S5; Table S4). SstmRNA expression was not changed in
any genotype at P1. Expression of several key islet transcription
factor genes that regulate either insulin or glucagon expression
was substantially increased specifically in DH, suggesting at-
tempts at compensation. However, expression of Pax4, a critical
b-cell differentiation factor (Sosa-Pineda et al., 1997), was unde-
tectable (Figure 5B), consistent with the reduction in insulin+
cells and the decrease in Pax4 expression in DH at E15.5 de-
tected by RNA-seq. Similarly, expression of genes involved in
glucose sensing and hormone-granule exocytosis was also
increased (Figure 5C). The bone morphogenetic protein (BMP)
inhibitor Sostdc1 was increased in DH P1 islets (Figure 5C),
possibly contributing to the impaired islet function (Henley
et al., 2012), as autocrine BMP activity was shown to be impor-
tant for glucose-stimulated insulin secretion (Goulley et al.,
2007).
We also observed increased expression of Ctgf, a b-cell-
derived growth factor that is critical for embryonic b-cell prolifer-
ation and capable of inducing proliferation of embryonic a- and
b-cells (Crawford et al., 2009; Guney et al., 2011; Riley et al.,
2015) (Figure 5C). The dramatically increased Ctgf expression
in DH suggested increased a- and/or b-cell proliferation as a
mechanism for restoring a- and b-cell mass by birth. Indeed,
Figure 3. Defective Differentiation of DH Hormone-Expressing Cells at E15.5
(A–D) WT, Pdx1LacZ/+, Oc1+/, and DH pancreata were immunolabeled for insulin (A), glucagon (B), MafA (C), or MafB (D) in red, E-Cadherin (green), and DAPI
(blue). The images are at 203 magnification. The scale bar represents 100 mm. p value for all marked comparisons was < 0.05 by one-way ANOVA with Tukey
correction (*p < 0.05). See also Figure S3.
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Figure 4. Defects in Glucose Homeostasis and Islet Gene Expression in DH Mice at P1
(A and B) Body weight (A) and ad lib feeding blood glucose measurements (B).
(C–F) Insulin (green) and glucagon (red) immunolabeling of pancreatic sections from WT (C), SH (D and E), and double heterozygotes (F).
(G–I) b cell mass (G), a cell mass (H), and a/b cell ratio (I).
(J) Total pancreatic insulin content (yp > 0.10, zp = 0.069, *p < 0.05, and **p < 0.01 by one-way ANOVA with Tukey correction).
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Figure 5. Combined Pdx1 and Oc1 Hetero-
zygosity Leads to Dramatic Alterations in
Neonatal Islet Gene Expression
(A–C) WT, Pdx1LacZ/+, Oc1+/, and Pdx1LacZ/+;
Oc1+/ islets were analyzed for gene expression of
hormones (A), endocrine-associated transcription
factors (B), and secretory functional genes (C).
p value for marked comparisons was < 0.05 by
Kruskal-Wallace Test followed by two-tailed Stu-
dent’s t test (*, WT versus Pdx1LacZ/+;Oc1+/; #,WT
versus Pdx1LacZ/+; ,^ WT versus Oc1+/; @,
Pdx1LacZ/+ versus Pdx1LacZ/+;Oc1+/; $, Oc1+/
versusPdx1LacZ/+;Oc1+/; and ?,Pdx1LacZ/+ versus
Oc1+/) (not detected = ND). See also Figure S5.we detected a significant increase in a- and b-cell proliferation
specifically in DH pancreata at E18.5 (Figure 6).
Restoration of Normal Glucose Homeostasis, but
Persistent Gene Expression Defects, in DH Animals at
Weaning
We next examined the DH phenotype at weaning when b cells
become functionally fully mature (Nishimura et al., 2006; Stolo-
vich-Rain et al., 2015). At this time point, DH animals had normal
body weight (data not shown) and normal fasting blood glucose
(Figure S6A). Ad lib blood glucose levels were elevated in Pdx1
SH (Figure S6B), consistent with the adult phenotype in the liter-
ature (Ahlgren et al., 1998; Brissova et al., 2002; Dutta et al.,
1998; Johnson et al., 2003). DH animals showed no statistically
significant difference in ad lib feeding blood glucose levels (Fig-
ure S6B). When challenged with glucose during an intraperito-
neal glucose tolerance test at 3 weeks of age, DH animals
were not glucose intolerant (Figure S6C).
Since the physiological phenotype of DH animals appeared to
resolve by weaning, we examined islet gene expression at
4weeks of age. Although expression of insulin could be detected
in DH islets at this age, it was still significantly reduced compared
with all other genotypes (Figure 7A). At this time point, expres-
sion of Sst was also reduced in DH islets. Expression levels of
islet transcription factors that were elevated in DH at P1 were
normalized at 4 weeks of age, with the exception ofMafA, whichCell Rremained significantly decreased (Fig-
ure 7B). Expression of genes involved in
glucose sensing and insulin secretion
was also restored to normal levels in DH
islets at 4 weeks (Figure 7C). Ctgf expres-
sion remained slightly elevated, while
Sostdc1 levels were normal (Figure 7C).
Expression of the remaining genes that
were abnormal at P1 was normalized by
weaning.
Oc1 is also expressed in liver and previ-
ous studies show that glycogenolysis and
gluconeogenesis are impaired in the
absence of Oc1 in the liver (Jacquemin
et al., 1999, 2000). To determine whether
a liver phenotype of Oc1 SH could be
contributing to the normalization ofglucose tolerance in DH mice by weaning, we examined
glycogen deposition. Indeed, Oc1 SH mice have increased
glycogen deposition in the liver postweaning compared to WT.
Pdx1 SH have reduced hepatic glycogen compared with WT,
likely due to decreased insulin output associated with the known
impairment in b-cell function in these animals. DH mice have
glycogen deposits that more closely resemble WT animals (Fig-
ure S7). Thus, the effects of the two genotypes on the liver
appear to counteract one another, and it is possible that the
‘‘normalization’’ of DH glucose tolerance at weaning reflects
compensation by the postnatal liver Oc1 heterozygous pheno-
type rather than resolution of the endocrine pancreas develop-
mental defect. The persistence of hormone gene expression
defects in 4-week-old DH islets supports this concept.
DISCUSSION
Pdx1 and Oc1 are co-expressed in MPCs very early in pancreas
development and our previous work suggested that these two
factors cooperate to regulate transcription of the endocrine pro-
genitor transcription factor Neurog3. We hypothesized that a
threshold of cooperative Pdx1 and Oc1 activity is required for
realization of the endocrine program from MPCs. Transcriptome
analyses of DH pancreas at E15.5 supported our hypothesis,
revealing a highly compromised islet differentiation program
with reduced expression of several key endocrine lineageeports 15, 2637–2650, June 21, 2016 2645
Figure 6. Increased a- and b-Cell Prolifera-
tion at E18.5 in DH Pancreata
(A and B) Representative images of proliferating b
cells (A; red: Glut2 and green: Ki67) and a cells
(B; red: glucagon and green: Ki67) at E18.5. a-cell
proliferation at E18.5. The arrows point to prolif-
erating hormone+ cells.
(C and D) Quantification of b-cell proliferation (C),
and quantification of a-cell proliferation (D). The
scale bar represents 100 mm (*p < 0.05; ***p <
0.001).transcription factors, including Neurog3 and Pax6, as well as
multiple genes involved in mature b-cell function. Complemen-
tary morphological and physiological studies point to distinct ef-
fects of combined Pdx1 Oc1 reduction in endocrine progenitor
specification and maturation with long-term effects on gene
expression and function.
Our findings highlight a specific role for combined Pdx1 and
Oc1 activity in establishing the endocrine progenitor program
during the second wave of endocrine differentiation. Decreased
dosage of Pdx1-Oc1 impacted Neurog3+ cell numbers and sub-
sequent endocrine differentiation at E15.5, but not at E13.5.
Since the duration of the Neurog3+ state is short (estimated to
be 12 hr) (Bankaitis et al., 2015), the reduced numbers of Neu-2646 Cell Reports 15, 2637–2650, June 21, 2016rog3+ cells at E15.5 suggest that endo-
crine progenitors are more sensitive to
Pdx1-Oc1 dosage after E13.5. The
normal number of glucagon+ and Pax6+
cells at E13.5, which derive from even
earlier Neurog3+ progenitors (Johansson
et al., 2007), supports this timeline of
events. The relative increase in the pro-
portion of delaminated cells expressing
high Neurog3 levels in DH pancreata sug-
gests that Pdx1 and Oc1 synergize to
regulate the timing of transition from a
Neurog3lo to Neurog3hi cell. The signifi-
cance of duration of the Neurog3lo state
is currently unclear, but may affect subse-
quent steps in endocrine maturation.
The morphologic and transcriptomic
analyses at E15.5 further suggest that
Pdx1-Oc1 reduction leads to defective
maturation of a- and b-cell lineages. This
could occur either directly by decreased
dosage of Pdx1 and Oc1 and/or indirectly
due to decreased expression of matura-
tional and other endocrine cell markers
per cell. The persistence of gene expres-
sion defects and elevated blood glucose
at P1 indicate that the endocrine matura-
tion program is not being completed suc-
cessfully by birth in DH embryos.
Our results suggest that the combined
activity of two structurally unrelated tran-
scription factors within a progenitor-cellpopulation affects subsequent differentiated cell populations
(a and b cells) in which the two factors are not coexpressed.
Expression of Pdx1 and Oc1 initially overlaps in MPCs and in bi-
potential duct/endocrine progenitors in the pancreatic epithelial
trunk, but they diverge with Oc1 silenced and Pdx1 maintained
almost exclusively in the pro-b cell lineage, as endocrine cells
become specified. It is possible that the cooperative activity of
Pdx1 and Oc1 in progenitors primes the cells for subsequent
steps of the differentiation program. This notion that transcrip-
tion factors can have temporally separated effects on cell
behavior is not novel, as deletion of Hnf4a in the embryonic liver
affects gene expression in differentiated hepatocytes long after
its expression is downregulated (Kyrmizi et al., 2006). Similarly,
Figure 7. Early Reductions in Pdx1 and Oc1
Lead to Persistent Alterations in Islet Gene
Expression at Weaning
(A–C) WT, Pdx1LacZ/+, Oc1+/, and DH islets were
analyzed for gene expression of hormones (A),
endocrine-associated transcription factors (B),
and secretory functional genes (C) at P28. p value
for marked comparisons were < 0.05 by Kruskal-
Wallace Test followed by two-tailed Student’s
t test (#, WT versus Pdx1LacZ/+; $, Oc1+/ versus
Pdx1LacZ/+;Oc1+/). See also Figure S6.the FoxD3 transcription factor, which is expressed in adult,
quiescent b cells is required for b-cell proliferation during preg-
nancy despite being absent from maternal b cells during preg-
nancy (Plank et al., 2011). Our preferred model is that Pdx1
and Oc1 cooperate in multi- or bipotent pancreatic progenitors
to establish a competency state that is realized in later stages
of differentiation. Consistent with the Pdx1-Oc1 interaction
occurring during a critical time sensitive period, inactivation of
oneOc1 allele in Pdx1 heterozygotes later in development, using
a later-acting pancreas-specific Cre driver line, did not impact
endocrine function (unpublished data).
The transcriptome of DH islets at P1 suggests potential mech-
anisms for the partial recovery of insulin-expressing cells by
birth, but also for the persistent defect in b-cell function. The
reduced hormone expression could result in a feedback loop
that upregulates expression of regulatory transcription factors
to promote further endocrine differentiation. Additionally, the
Oc1 target Ctgf is essential for embryonic b-cell proliferation;
increased Ctgf expression in embryonic b cells induces both a-
and b-cell proliferation, resulting in increased a- and b-cell
mass at birth (Guney et al., 2011). The dramatic increase in
Ctgf expression in DH islets likely increased a- and b-cell prolif-
eration, thereby increasing a- and b-cell mass by P1. It is alsoCell Rpossible that decreased insulin expres-
sion itself stimulates increased b-cell pro-
liferation during late gestation. Mice with
targeted disruption of both insulin genes
in early development exhibit increased
b-cell proliferation at E18.5, similar to the
DH animals (Duvillie´ et al., 2002). Reduc-
tion in insulin and glucagon expression
persists at P1, which likely contributes to
impaired glucose homeostasis. In addi-
tion, the increase in Sostdc1 could impair
b-cell function. Sostdc1 is a BMP inhibitor
and autocrine BMP signaling was sug-
gested to enhance insulin secretion and
glucose homeostasis (Goulley et al.,
2007). Indeed, inactivation of Sostdc1 en-
hances glucose-stimulated insulin secre-
tion and glucose homeostasis (Henley
et al., 2012). We were surprised to
observe that glycemic control is restored
in the majority of DH animals by weaning.
Sostdc1 expression was no longerelevated and most islet transcription factors, including Pax4,
had returned to normal expression levels. However, decreases
in insulin and glucagon expression persisted, now along with
reduced MafA expression. Loss of MafA is associated with
impaired b-cell function in adult mice (Artner et al., 2010; Zhang
et al., 2005). Thus, it is likely that islets from DH animals still have
reduced functionality.
Taken together, our results suggest that Pdx1 and Oc1 coop-
erate within pancreaticMPCs or bipotential trunk cells to promote
endocrine specification and to establish a permissive state that al-
lows for later steps of endocrine differentiation and function.
Together, these two transcription factors initiate a network of
gene expression beyond simple activation of the endocrine pro-
genitor determinant, Neurog3. The concerted action of Oc1 and
Pdx1 is critical for the timely functional maturation of endocrine
cells. Their cooperative role in ESC or iPSC differentiation toward
functionalbcells hasnotbeenexploredandshouldbeconsidered.EXPERIMENTAL PROCEDURES
Mutant and Transgenic Mice
Pdx1XSLacZ (Pdx1LacZ) animals are described in Offield et al. (1996).Oc1 floxed
mice are described in Zhang et al. (2009). The Pdx1-Cre and Protamine-Creeports 15, 2637–2650, June 21, 2016 2647
(Prm-Cre) transgenes are described in Hingorani et al. (2003) and O’Gorman
et al. (1997). The Rosa26-EYFP allele is described in Srinivas et al. (2001).
Mice were on a mixed genetic background, were maintained on a 12 hr
light/dark cycle, and provided food and water ad libitum (except where
indicated). All mouse experiments were approved by the Institutional Animal
Care and Use Committee of Vanderbilt University Medical Center. Genotyping
was performed using tail or ear punch DNA and the primer sets listed in
Table S3.
Tissue Dissection, Preparation, and Histology
The morning of the vaginal plug was defined as E0.5. Digestive organs were
fixed for 1–4 hr in 4% paraformaldehyde (PFA) at 4C, dehydrated, cleared in
Citrisolv (Fisher) or xylenes, and embedded in paraffin. Livers were fixed
24 hr in 4% PFA at 4C, dehydrated, cleared in xylenes, and embedded in
paraffin. For frozen embedding, tissue was fixed as above and placed in
30% sucrose overnight. Following 30 min in 50/50 FSC22 (frozen section
compound, Leica) and 30% sucrose, frozen tissues were embedded in
100% FSC22 and frozen on dry ice. Paraffin embedded and FSC22
embedded tissues were cut at 5 mm and 7 mm, respectively. Paraffin-
embedded tissues were deparaffinzed in Citrisolv or xylenes and rehydrated;
frozen tissues were allowed to thaw for 30 min and permeabilized in 0.1%
Triton 2 3 15 min in 13 PBS. Detection of MafA, MafB, glucagon, Pax6,
and synaptophysin required antigen retrieval. Neurog3 immunolabeling
required amplification with PerkinElmer tyramide tissue amplification. Anti-
body information is found in Supplemental Information. X-gal staining was
performed as previously described (Wu et al., 1997). Periodic acid Schiff
staining was performed following manufacturer’s protocol (Sigma-Aldrich).
Fluorescent and bright field images were captured using an Olympus BX41
microscope, the Aperio ScanScope microscope and slide scanner, or Nikon
600. Digital images were captured and quantified using MagnaFire software
(Optronics Engineering), ImageScope software of the Aperio software suite
for the insulin, glucagon, MafA, and MafB, or MetaMorph software for the
Neurog3 and Pax6.
b Cell Mass, a/b Cell Area, and a:b Ratio
b cell mass was analyzed as in Riley et al. (2015). For a- or b-cell area, whole
pancreata were serially sectioned at 5 mmand sections every 250 mm immuno-
labeled for insulin and glucagon. At least 1%–2% of the entire pancreas was
imaged. Slides were imaged using MetaMorph or a macro built in Genie
(Aperio System). Proportional insulin/glucagon-positive area was calculated
by adding the insulin-positive and glucagon-positive area of each section
and dividing it by the total pancreas area of each section. a:b cell ratio was
calculated by dividing the number of glucagon-positive cells by the number
of insulin-positive cells. Total endocrine area was calculated by measuring to-
tal area staining positive for synaptophysin as in Zhang et al. (2009).
Quantitative Real-Time PCR and TaqMan Low Density Array
Islet isolation required collagenase digestion of whole pancreas at 37C and
hand-picking of islets from exocrine tissue. Islets were placed immediately
in 500 ml TRIzol reagent or RNAlater (Ambion), lysed by vortexing or homoge-
nized using a Tissuemiser (Fisher Scientific), and RNA was isolated using the
RNAqueous (Ambion) or RNeasy Micro/Mini Kits (QIAGEN). RNA con-
centration and integrity were assessed using a ND-1000 Spectrophotometer
(NanoDrop) and the 2100 Electrophoresis Bioanalyzer (Agilent) at Vanderbilt
Technologies for Advanced Genomics (VANTAGE) Core. cDNA generated
from neonatal islets required amplification with the SMARTer Pico PCR
cDNA Synthesis Kit (Clontech). cDNA was prepared from 50–350 ng islet or
pancreas RNA using the Superscript III First-Strand Synthesis System (Invitro-
gen). Real-time reactions were carried out in technical duplicates with iQ SYBR
Green Supermix (Bio-Rad) on a CFX Real-Time PCR Detection System (Bio-
Rad) in the Vanderbilt Molecular and Cellular Biology Resource Core. Primers
used for hormone gene expression are listed in Table S3. TLDA required 150–
300 ng cDNA. Genes were analyzed using TaqMan Universal PCR Mastermix
(with UNG, Applied Biosystems) on custom-designed TLDA cards using a
7900HT Fast Real-Time PCR System. Data were analyzed using SDS RQ
Study software (Applied Biosystems, Life Technologies). All samples were
run in triplicate.2648 Cell Reports 15, 2637–2650, June 21, 2016Pancreatic Insulin Content and Glucose Homeostasis
Pancreatic insulin content was measured as described in Zhang et al. (2009).
Intraperitoneal glucose tolerance tests (IPGTT) were performed as in Henley
et al. (2012).
Statistics
Results are expressed as mean + SEM. Statistical significance was calculated
by Student’s t test, one-way ANOVA with Tukey correction, or two-way
ANOVA where applicable. p < 0.05 was considered significant.ACCESSION NUMBER
The accession number for the RNA-seq data reported in this paper is GEO:
GSE77896.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and four tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2016.05.040.
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